In general, several therapeutic agents can improve endothelial vasodilator function and insulin resistance: pioglitazone, metformin, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II-receptor antagonists (AT1-receptor blockers) [8]. Here, ACE is linked to Insulin resistance.